A 22-year-old woman with cystic fibrosis developed QTc interval prolongation following lung transplantation in the setting of voriconazole therapy. After the discontinuation of voriconazole and initiation of isavuconazole, her QTc interval normalized. This case highlights the unique property of QTc interval shortening by isavuconazole among the triazole antifungals.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/tid.12712 | DOI Listing |
Publication Analysis
Top Keywords
qtc interval
12
isavuconazole patient
4
patient voriconazole-induced
4
qtc
4
voriconazole-induced qtc
4
qtc prolongation
4
prolongation 22-year-old
4
22-year-old woman
4
woman cystic
4
cystic fibrosis
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!